Risk factor | Odds ratio | 95 % C.I. | P-value |
---|---|---|---|
CKD risk factors | Â | Â | Â |
 Smoking | 0.7 | 0.19–2.53 | 0.59 |
 Hypertension | 2.3 | 0.79–6.66 | 0.12 |
 Dyslipidemia | 2.25 | 0.70–7.20 | 0.17 |
 Use of NSAIDs | 3.56 | 1.11–11.39 | 0.04 |
 Obesity | 0.51 | 0.10–2.50 | 0.4 |
 Diabetes mellitus | 0.91 | 0.17–4.70 | 0.91 |
 Hyperuricemia | 1.05 | 0.20–5.57 | 0.95 |
 Urinary tract stone | - |  | 0.12 |
 Age ≥70 | 0.5 | 0.06–4.31 | 0.52 |
 Cardiac disease | 6 | 1.21–29.87 | 0.04 |
 Hematuria | - |  | 0.29 |
 Cerebrovascular disease | - |  | 0.29 |
 Autoimmune disease | 4 | 0.52–30.61 | 0.15 |
 Proteinuria | - |  | 0.6 |
 Infectious disease | - |  | - |
 Past history of ARF | - |  | - |
 Pt. with CKD risk | - |  | 0.29 |
 Pt. without CKD risk | - |  | 0.29 |
No. of CKD risk factors | Â | Â | Â |
 ≤2 | 1 |  |  |
 3 | 1.54 | 0.39–5.96 | 0.72 |
 4 | 1.5 | 0.34–6.7 | 0.69 |
 ≥5 | 5 | 0.85–29.39 | 0.09 |
Other risk factors | Â | Â | Â |
 PS ≥1 | 0.68 | 0.23–2.01 | 0.48 |
 Alb <3.5 g/dL | 0.69 | 0.24–1.97 | 0.49 |
 Female | 1.43 | 0.44–4.69 | 0.56 |
Anticancer drugs | Â | Â | Â |
 Vinorelbine | 1 | 0.35–3.25 | 0.9 |
 Etoposide | 2.44 | 0.70–8.49 | 0.15 |
 Docetaxel | 0.7 | 0.14–3.53 | 0.66 |
 Pemetrexed | 0.33 | 0.04–2.76 | 0.29 |
 Gemcitabine | 3.94 | 0.51–30.14 | 0.16 |
 S-1 | 3.94 | 0.51–30.14 | 0.16 |